Results 131 to 140 of about 169,884 (264)

Severe and disseminated atypical mycobacteriosis of the skin under immunosuppression

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Veronika Zenderowski, Laura Schreieder, Mark Berneburg, Dennis Niebel, Sebastian Haferkamp, Sigrid Karrer, Konstantin Drexler   +6 more
wiley   +1 more source

Longitudinal urinary LAM measurements in pulmonary tuberculosis patients: preliminary observations. [PDF]

Trop Med Health
Kolokotroni V, Gerogianni I, Gourgoulianis KI, Perlepe G.   +3 more
europepmc   +1 more source

AIRBORNE PULMONARY TUBERCULOSIS

Bacteriological Reviews, 1961
openaire   +2 more sources

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

Drug Resistance in Extrapulmonary Tuberculosis in Korea, 2010-2019: A Comparison With Pulmonary Tuberculosis. [PDF]

J Korean Med Sci
Kim S, Jeon D, Lee T, Lee SJ, Lee HY, Kang BH, Mok J.   +6 more
europepmc   +1 more source

Pulmonary Tuberculosis [PDF]

American Journal of Public Health and the Nations Health, 1928
openaire   +1 more source

The Role of Belatacept‐Use and Senescence on Infectious and Mortality Complications After Kidney Transplantation

Transplant Infectious Disease, EarlyView.
ABSTRACT Introduction Studies evaluating the incidence of infections after belatacept as a substitute for calcineurin inhibitors (CNI) or antimetabolite in kidney transplant (KT) yielded conflicting results. We compared infectious outcomes after belatacept‐use to no belatacept‐use in KT recipients.
Hareesh Singam, Abdinoor Abdi, Wyatt Tarter, Ben Langworthy, Adam Bregman, Karam M. Obeid   +5 more
wiley   +1 more source

Self-management and sputum conversion in pulmonary tuberculosis: a prospective study. [PDF]

BMC Infect Dis
Jiang C, Luo X.
europepmc   +1 more source

Risk factors for cholera mortality: A scoping review

Tropical Medicine &International Health, Volume 30, Issue 5, Page 332-350, May 2025.
Abstract Objectives Cholera is an easily treatable disease, but many people are still unnecessarily dying from it. To improve current case management practices and prevent mortality requires a comprehensive understanding of who is at higher risk of dying.
Despina Pampaka, Kathryn Alberti, David Olson, Iza Ciglenecki, Philippe Barboza   +4 more
wiley   +1 more source

Prevalence of Hypercalcemia in Patients With Pulmonary Tuberculosis and Impact of Treatment. [PDF]

Cureus
Naina N, Dhamija KS.
europepmc   +1 more source